Sam Alworth

Mr. Samuel V. Alworth, MS, MBA, Chief Executive Officer and Co-Founder, has nearly 20 years’ experience in the life sciences covering research, drug development and business development. Since co-founding AcuraStem, he has been actively involved in advancing drug candidates for ALS / FTD. With a background in machine learning and image recognition, Sam has led the implementation of new informatics pipelines at AcuraStem, incorporating both innovative machine learning and traditional image processing algorithms into a Unix based cloud-distributable pipeline leveraging best-in-class open source algorithms for the iNeuroRx® platform. Prior to co-founding AcuraStem, Mr. Alworth was VP of Sales & Marketing at DRVision Technologies LLC (Bellevue, WA), where he led the development of an artificial intelligence enabled software for automated microscopy (SVCell, now Aivia). Sam has several U.S. patents and scientific journal publications. He also speaks Chinese.